Yoshihisa Shitara
- Pharmacology top 0.05%
- Drug-Induced Hepatotoxicity and Protection 9
- Pharmacogenetics and Drug Metabolism 9
- Inflammatory mediators and NSAID effects 4
- Antibiotics Pharmacokinetics and Efficacy 4
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 30
-
- Pharmacological Effects and Toxicity Studies 17
- Transplantation top 5%
- Biochemistry top 2%
-
- HIV/AIDS drug development and treatment 9
-
- Metabolism and Genetic Disorders 5
- Co-authors
- Yuichi SugiyamaToshiharu HorieKazuya MaedaMasaru HiranoHitoshi SatoHiroyuki KusuharaAlbert P. LiTakao Watanabe
- Journals
- Gastroenterology (1 paper)Journal of Controlled Release (1 paper)Journal of Pharmacology and Experimental Therapeutics (6 papers)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Yoshihisa Shitara
47 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Pharmacology 1.8k
- Oncology 2.9k
- Pediatrics, Perinatology and Child Health 1.6k
- Transplantation 96
- Biochemistry 211
Countries citing papers authored by Yoshihisa Shitara
This map shows the geographic impact of Yoshihisa Shitara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihisa Shitara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihisa Shitara more than expected).
Fields of papers citing papers by Yoshihisa Shitara
This network shows the impact of papers produced by Yoshihisa Shitara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihisa Shitara. The network helps show where Yoshihisa Shitara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshihisa Shitara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2019 | 1 | |
| 4 | 2015 | 52 | |
| 5 | 2013 | 3 | |
| 6 | 2013 | 4 | |
| 7 | 2012 | 43 | |
| 8 | 2012 | 48 | |
| 9 | 2012 | 37 | |
| 10 | 2011 | 93 | |
| 11 | 2010 | 32 | |
| 12 | 2010 | 63 | |
| 13 | 2008 | 279 | |
| 14 | Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug–drug interactions and interindividual differences in transporter and metabolic enzyme functionsbreakdown → | 2006 | 464 |
| 15 | 2004 | 376 | |
| 16 | 2003 | 264 | |
| 17 | 2003 | 86 | |
| 18 | 2002 | 98 | |
| 19 | 2001 | 102 | |
| 20 | 1998 | 18 |
About Yoshihisa Shitara
Yoshihisa Shitara is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 47 papers that have together received 4.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (30 papers), Pharmacological Effects and Toxicity Studies (17 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Pharmacogenetics and Drug Metabolism (9 papers), HIV/AIDS drug development and treatment (9 papers), Metabolism and Genetic Disorders (5 papers), Inflammatory mediators and NSAID effects (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Pharmacology (1.8k citations), Oncology (2.9k citations) and Pediatrics, Perinatology and Child Health (1.6k citations). Yoshihisa Shitara has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Yuichi Sugiyama, Toshiharu Horie, Kazuya Maeda, Masaru Hirano, Hitoshi Sato, Hiroyuki Kusuhara, Albert P. Li, Takao Watanabe, Shuichi Sekine and Kenta Yoshida. Their work appears in journals such as Gastroenterology, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.